logo

For the Inventor, By the Inventor

Aurangabad, India

Milind Chintaman Shukla

This inventor holds 10 USPTO granted patents, plus 1 CIPO patent. Top assignee: Wockhardt Limited. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Milind Chintaman Shukla. Retrieved from https://idiyas.com/inventor/milind-chintaman-shukla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10


Average Co-Inventor Count = 9.5

ph-index = 3

Forward Citations = 57(Granted Patents)


Location History:

  • Cidco, IN (2005)
  • Chikalthana Aurangabad, IN (2008)
  • Aurangabad, IN (2003 - 2009)
  • Maharashtra State, IN (2010 - 2014)

Company Filing History:

goldMedal10 out of 117 
 
Wockhardt Limited
 patents

Years Active: 2003-2014

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8729269 - Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy (2014-05-20),
2. 7687627 - Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy (2010-03-30),
3. 7626032 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2009-12-01),
4. 7405228 - Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites (2008-07-29),
5. 7393957 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2008-07-01),
6. 7132541 - Crystalline fluoroquinolone arginine salt form (2006-11-07),
7. 7098219 - Inhibitors of cellular efflux pumps of microbes (2006-08-29),
8. 6964966 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2005-11-15),
9. 6878713 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2005-04-12),
10. 6664267 - Crystalline fluoroquinolone arginine salt form (2003-12-16),

Title: Milind Chintaman Shukla: Innovator in Antimicrobial Agents

Introduction

Milind Chintaman Shukla is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of antimicrobial agents, holding a total of 10 patents. His work focuses on developing innovative solutions for preventing and treating infectious diseases.

Latest Patents

One of his latest patents includes the invention of substituted piperidino phenyloxazolidinones that exhibit antimicrobial activity with improved in vivo efficacy. This invention provides novel agents aimed at preventing and treating infectious diseases. The patent details processes for creating these compounds, as well as antimicrobial compositions that contain these derivatives as active ingredients. Furthermore, it outlines methods for treating bacterial infections using these innovative derivatives.

Career Highlights

Throughout his career, Milind has worked with prominent companies, including Wockhardt Limited. His experience in the pharmaceutical industry has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.

Collaborations

Milind has collaborated with notable professionals in his field, including Mahesh Vithalbhai Patel and Prasad Keshav Deshpande. These collaborations have further enhanced his research and development efforts.

Conclusion

Milind Chintaman Shukla's contributions to antimicrobial research and his innovative patents highlight his role as a significant inventor in the medical field. His work continues to impact the treatment of infectious diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…